Research progress in influences of epigenetic modifications on PD-L1 expression in tumors
10.3760/cma.j.cn371439-20220323-00065
- VernacularTitle:表观遗传修饰对肿瘤PD-L1表达调控的研究进展
- Author:
Yue WANG
1
;
Qun HU
;
Yingwei HOU
Author Information
1. 内蒙古医科大学第一临床医学院,呼和浩特 010050
- Keywords:
Neoplams;
Epigenetic regulation;
PD-L1
- From:
Journal of International Oncology
2022;49(6):345-348
- CountryChina
- Language:Chinese
-
Abstract:
Tumor cells expression of programmed death ligand-1 (PD-L1) is a major mechanism of immune escape and a predictor of therapeutic efficacy of immune checkpoint inhibitors. The expression of PD-L1 is regulated by a variety of mechanisms, among which epigenetic modifications such as DNA methylation, histone modification and non-coding RNA can promote the occurrence, development and drug resistance of tumors by regulating the expression of PD-L1. To clarify its regulation mechanism can bring new ideas for clinical immunotherapy of tumors.